Arbaclofen placarbil
id:
arbaclofen-placarbil-185-3911165
title:
Arbaclofen placarbil
text:
Arbaclofen placarbil is a prodrug of R-baclofen. Arbaclofen placarbil possesses more favorable pharmacokinetic profile than baclofen, with less fluctuations in plasma drug levels. It was being developed as a potential treatment for patients with GERD and spasticity due to multiple sclerosis; however, in May 2013 XenoPort announced the termination of development because of unsuccessful results in phase III clinical trials. It is being developed as an addiction medicine to treat alcoholism. It is
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Arbaclofen_placarbil
date created:
2013-06-03T13:11:35Z
date modified:
2024-09-07T17:25:19Z
main entity:
{"identifier":"Q15408425","url":"https://www.wikidata.org/entity/Q15408425"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/2/28/Arbaclofen_placarbil.svg","width":619,"height":367}
fields total:
13
integrity:
16